about
Specific transfection of inflamed brain by macrophages: a new therapeutic strategy for neurodegenerative diseasesCan nanomedicines kill cancer stem cells?Nanoscale drug delivery systems and the blood-brain barrierCell or cell membrane-based drug delivery systemsEvolving Drug Delivery Strategies to Overcome the Blood Brain Barrier.Cell delivery of therapeutic nanoparticlesNanoparticle Uptake: The Phagocyte ProblemGDNF-transfected macrophages produce potent neuroprotective effects in Parkinson's disease mouse modelNanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases.Irradiation Enhances the Ability of Monocytes as Nanoparticle Carrier for Cancer Therapy.Drug delivery strategies to enhance the permeability of the blood-brain barrier for treatment of gliomaEnhanced antidepressant-like effects of the macromolecule trefoil factor 3 by loading into negatively charged liposomes.Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins.Cell-mediated delivery of nanoparticles: taking advantage of circulatory cells to target nanoparticles.Agile delivery of protein therapeutics to CNSCo-opting biology to deliver drugsTowards nanomedicines for neuroAIDS.Long-acting antituberculous therapeutic nanoparticles target macrophage endosomes.An optimized nanoparticle delivery system based on chitosan and chondroitin sulfate molecules reduces the toxicity of amphotericin B and is effective in treating tegumentary leishmaniasisQuantitative evaluation of ultrasound-mediated cellular uptake of a fluorescent model drug.Development of HIV reservoir targeted long acting nanoformulated antiretroviral therapiesMonocytes-derived macrophages mediated stable expression of human brain-derived neurotrophic factor, a novel therapeutic strategy for neuroAIDS.Prolonged-acting, multi-targeting gallium nanoparticles potently inhibit growth of both HIV and mycobacteria in co-infected human macrophages.Stem cell-mediated delivery of SPIO-loaded gold nanoparticles for the theranosis of liver injury and hepatocellular carcinoma.Microencapsulating and Banking Living Cells for Cell-Based Medicine.Blood-borne macrophage-neural cell interactions hitchhike on endosome networks for cell-based nanozyme brain delivery.The mixed lineage kinase-3 inhibitor URMC-099 improves therapeutic outcomes for long-acting antiretroviral therapyTargeted and controlled anticancer drug delivery and release with magnetoelectric nanoparticles.Pharmacodynamic and antiretroviral activities of combination nanoformulated antiretrovirals in HIV-1-infected human peripheral blood lymphocyte-reconstituted mice.Non-affinity factors modulating vascular targeting of nano- and microcarriersMacrophage folate receptor-targeted antiretroviral therapy facilitates drug entry, retention, antiretroviral activities and biodistribution for reduction of human immunodeficiency virus infectionsExploiting macrophages as targeted carrier to guide nanoparticles into glioma.Rottlerin-induced autophagy leads to the apoptosis in breast cancer stem cells: molecular mechanisms.Novel targeting using nanoparticles: an approach to the development of an effective anti-leishmanial drug-delivery system.Targeted delivery of doxorubicin by nano-loaded mesenchymal stem cells for lung melanoma metastases therapyA complete compilation of matrix metalloproteinase expression in human malignant gliomas.Biomaterial-based scaffolds--current status and future directions.Macrophages associated with tumors as potential targets and therapeutic intermediates.Cancer stem cells and personalized cancer nanomedicine.Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems.
P2860
Q21133553-2314796E-620D-4E8A-B0D5-197569FD77A8Q27022017-568A0F74-EC38-46FD-8C65-C1CF413D77A2Q27026978-5AF9D44E-3975-4109-89FB-25C2382C358BQ28080710-56977928-A485-4D09-A2A9-8AC85E0D7143Q28082016-1E04CD3B-18A8-4588-8EB3-B4541360DF7FQ28385606-9A31C5BC-A472-49EE-8A06-6B14F470E2A9Q28395287-F12BB43A-7C32-4A9D-AFB3-981E152E7EA7Q28543023-15F8BA2B-D975-43F8-8D4F-507FB4923EDBQ30387307-4E15A6BF-284F-4623-92C1-305BD62A369FQ30401659-16D18BA3-FDE5-419C-9A6F-9438C79C3C1AQ30413487-A3D984F1-8AE5-4925-82C7-EADFE9F5AC26Q30425498-55D10E8A-2CED-4623-AEC8-0F773AE135A1Q33631069-182E5AFD-99EC-4B9C-A429-B6089C476A8BQ34079604-D6E55620-3C52-4A70-8C02-FB4583296008Q34079647-20248BB6-EDD1-4E99-A2EA-9B03E1661935Q34424045-63F8B6DF-EDB2-4AA7-9E31-7DA38954EACAQ34495140-3E399919-727E-466E-938A-77CF80BE7A87Q34512904-8414251D-F1BF-44C8-BA87-1FBB8E4CB44DQ34565059-C7D06573-E1B2-45C1-815D-A48B43841C16Q34616406-FFF9CD53-F79E-4D91-BDF4-3BED6099CA53Q34797004-B04E1D18-7DF7-4AD1-9F55-00789D597E72Q35088011-2975EF98-1637-41CC-94FD-6CA64BE68FB3Q35153311-1303EF7D-CC66-4151-88AE-D90BED113BB9Q35247691-AABC4ADC-DED5-4B7A-8C65-66DC94AD0749Q35611428-A62C586A-B067-4F42-9304-3822713D723CQ36063039-BCD376A6-8764-44F5-BD14-23ECC0C5ED86Q36505647-17D608B2-19B5-472A-94CA-A27662E4F66BQ36579751-D65D9586-A382-4AF2-B660-30AD260E7895Q36603756-31C17433-A49E-48A5-93F4-9175EC48452DQ36703526-20DF7FA6-9194-441D-98F5-20A46DBFC812Q37188867-58B1E65C-5087-4F68-B1D7-F8AB56BC9CE3Q37392913-B9138F4B-2159-444B-ACC7-B3D058013894Q37556841-E02FA620-6F8A-4143-ABC7-064FD044CCEAQ37597619-549A005C-3FF5-46AF-831B-555BEF590779Q37708056-327B4229-E398-40C8-855A-C262629BC1E8Q38009800-3CA19D6F-7F18-4872-8073-25C81AFB3CE2Q38199519-99729FB4-B042-4474-A390-0C415327C27AQ38211726-15DB7796-4EBA-4B4F-90FD-27E2CD354072Q38702970-638A561E-BF9F-405A-A4A1-8602100D3FDEQ38760096-02EC5C29-CE74-4CE9-8A27-2F806EEC3B4B
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Cell-mediated drug delivery.
@ast
Cell-mediated drug delivery.
@en
Cell-mediated drug delivery.
@nl
type
label
Cell-mediated drug delivery.
@ast
Cell-mediated drug delivery.
@en
Cell-mediated drug delivery.
@nl
prefLabel
Cell-mediated drug delivery.
@ast
Cell-mediated drug delivery.
@en
Cell-mediated drug delivery.
@nl
P2860
P1476
Cell-mediated drug delivery
@en
P2093
Elena V Batrakova
Howard E Gendelman
P2860
P304
P356
10.1517/17425247.2011.559457
P407
P50
P577
2011-02-24T00:00:00Z